Linda A. DiMeglio

Linda A. DiMeglio

Indiana University Bloomington

H-index: 70

North America-United States

About Linda A. DiMeglio

Linda A. DiMeglio, With an exceptional h-index of 70 and a recent h-index of 55 (since 2020), a distinguished researcher at Indiana University Bloomington, specializes in the field of Endocrinology, Pediatrics, Diabetes, Metabolic Bone Disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Invited Mini Review Metabolic Bone Disease of Prematurity: Overview and Practice Recommendations

Endpoints for clinical trials in type 1 diabetes drug development

Pediatric Endocrine Society Statement on Considerations for Use of Teplizumab (Tzield™) in Clinical Practice

Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review

Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6 …

Metabolic bone disease of prematurity screening and individualized enteral mineral supplementation in high-risk neonates: a quality improvement initiative

Twelve‐month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes

THU277 Deletion Or inhibition Of Ornithine Decarboxylase Protects Islet β-cell Health And Is Associated With Preserved Residual C-peptide In Persons With Recent Onset Type 1 …

Linda A. DiMeglio Information

University

Position

School of Medicine

Citations(all)

21763

Citations(since 2020)

14251

Cited By

12444

hIndex(all)

70

hIndex(since 2020)

55

i10Index(all)

180

i10Index(since 2020)

153

Email

University Profile Page

Google Scholar

Linda A. DiMeglio Skills & Research Interests

Endocrinology

Pediatrics

Diabetes

Metabolic Bone Disease

Top articles of Linda A. DiMeglio

Title

Journal

Author(s)

Publication Date

Invited Mini Review Metabolic Bone Disease of Prematurity: Overview and Practice Recommendations

Monica Grover

Ambika P Ashraf

Sasigarn A Bowden

Andrew Calabria

Alicia Diaz-Thomas

...

2024/1/11

Endpoints for clinical trials in type 1 diabetes drug development

Alfonso Galderisi

Brynn E Marks

Linda A DiMeglio

Carine de Beaufort

2024/5

Pediatric Endocrine Society Statement on Considerations for Use of Teplizumab (Tzield™) in Clinical Practice

Hormone Research in Paediatrics

Shilpa Mehta

Anna Ryabets-Lienhard

Neha Patel

Emily Breidbart

Ingrid Libman

...

2024/4/25

Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review

Jamie L Felton

Maria J Redondo

Richard A Oram

Cate Speake

S Alice Long

...

2024/4/6

Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6 …

Journal of Diabetes Science and Technology

D Steven Fox

Julia Ware

Charlotte K Boughton

Janet M Allen

Malgorzata E Wilinska

...

2024/3/17

Metabolic bone disease of prematurity screening and individualized enteral mineral supplementation in high-risk neonates: a quality improvement initiative

Journal of Perinatology

Priya V Creed

Katie A Huff

Kate Beard

Linda A DiMeglio

Beatrice M Stefanescu

2024/2/6

Twelve‐month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes

Diabetic Medicine

Persis V Commissariat

Linda A DiMeglio

Lauren G Kanapka

Lori M Laffel

Kellee M Miller

...

2023/8

THU277 Deletion Or inhibition Of Ornithine Decarboxylase Protects Islet β-cell Health And Is Associated With Preserved Residual C-peptide In Persons With Recent Onset Type 1 …

Journal of the Endocrine Society

Batoul Hammoud

Linda A DiMeglio

Abishek Kulkarni

Audrey Hull

Stephanie Woerner

...

2023/10

Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial

Diabetes technology & therapeutics

Satish K Garg

George Grunberger

Ruth Weinstock

Margaret L Lawson

Irl B Hirsch

...

2023/1/1

Barriers to screening: an analysis of factors impacting screening for type 1 diabetes prevention trials

Journal of the Endocrine Society

Mara Kinney

Lu You

Emily K Sims

Diane Wherrett

Desmond Schatz

...

2023/3/1

Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes

Diabetes, Obesity and Metabolism

Simon Heller

Tadej Battelino

Timothy S Bailey

Thomas R Pieber

Ulrike Hövelmann

...

2023/5

Interventions to address global inequity in diabetes: international progress

Ashby F Walker

Sian Graham

Louise Maple-Brown

Leonard E Egede

Jennifer A Campbell

...

2023/7/15

SAT107 Assessing Continuous Glucose Monitor Alarm Use By Families Of Children With Diabetes

Journal of the Endocrine Society

Victoria S Ochs

Stephanie E Woerner

Ala Ustyol

Linda A DiMeglio

2023/10

Inhibition of polyamine biosynthesis preserves β cell function in type 1 diabetes

Cell Reports Medicine

Emily K Sims

Abhishek Kulkarni

Audrey Hull

Stephanie E Woerner

Susanne Cabrera

...

2023/11/21

Strategies to reduce food insecurity for people with diabetes: a call to action

Diabetes care

Judith Wylie-Rosett

Linda A DiMeglio

2023/2

Precision diagnostics: using islet autoantibodies to characterize heterogeneity in type 1 diabetes

medRxiv

Jamie L Felton

Maria J Redondo

Richard A Oram

Cate Speake

S Alice Long

...

2023/4/19

Long-term continuous glucose monitor use in very young children with type 1 diabetes: one-year results from the SENCE study

Journal of Diabetes Science and Technology

Michelle A Van Name

Lauren G Kanapka

Linda A DiMeglio

Kellee M Miller

Anastasia Albanese-O’Neill

...

2023/7

THU180 Evaluation Of Factors Affecting Changes In Body Mass Index In Childhood Brain Tumor Survivors

Journal of the Endocrine Society

Dana Chatila

Linda A DiMeglio

Daniel Runco

Nadine G Haddad

2023/10

Hydroxychloroquine in Stage 1 Type 1 Diabetes

Diabetes care

Ingrid Libman

Polly J Bingley

Dorothy Becker

Jane H Buckner

Linda A DiMeglio

...

2023/11/1

Gut microbial changes associated with obesity in youth with type 1 diabetes.

medRxiv

Heba M Ismail

Dimuthu Perera

Rabindra Mandal

Linda A DiMeglio

Carmella Evans Molina

...

2023

See List of Professors in Linda A. DiMeglio University(Indiana University Bloomington)

Co-Authors

academic-engine